These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11377408)

  • 41. 3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humans.
    Gamma A; Buck A; Berthold T; Liechti ME; Vollenweider FX
    Neuropsychopharmacology; 2000 Oct; 23(4):388-95. PubMed ID: 10989265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Naltrexone alteration of the nicotine-induced EEG and mood activation response in tobacco-deprived cigarette smokers.
    Knott VJ; Fisher DJ
    Exp Clin Psychopharmacol; 2007 Aug; 15(4):368-81. PubMed ID: 17696684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers.
    Benkelfat C; Bradwejn J; Meyer E; Ellenbogen M; Milot S; Gjedde A; Evans A
    Am J Psychiatry; 1995 Aug; 152(8):1180-4. PubMed ID: 7625467
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia.
    Dalack GW; Becks L; Hill E; Pomerleau OF; Meador-Woodruff JH
    Neuropsychopharmacology; 1999 Aug; 21(2):195-202. PubMed ID: 10432467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiple previous alcohol detoxifications are associated with decreased medial temporal and paralimbic function in the postwithdrawal period.
    George MS; Tenebäck CC; Malcolm RJ; Moore J; Stallings LE; Spicer KM; Anton RF; Ballenger JC
    Alcohol Clin Exp Res; 1999 Jun; 23(6):1077-84. PubMed ID: 10397294
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sequential regional cerebral blood flow brain scans using PET with H2(15)O demonstrate ketamine actions in CNS dynamically.
    Holcomb HH; Lahti AC; Medoff DR; Weiler M; Tamminga CA
    Neuropsychopharmacology; 2001 Aug; 25(2):165-72. PubMed ID: 11425500
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray.
    Myers CS; Taylor RC; Moolchan ET; Heishman SJ
    Neuropsychopharmacology; 2008 Feb; 33(3):588-98. PubMed ID: 17443125
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking.
    Rose JE; Behm FM; Westman EC
    Pharmacol Biochem Behav; 2001 Feb; 68(2):187-97. PubMed ID: 11267622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A single photon emission computerized tomography (SPECT) study of regional cerebral blood flow in bipolar disorder.
    Bhardwaj R; Chakrabarti S; Mittal BR; Sharan P
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):334-43. PubMed ID: 20218796
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Imaging the neurochemistry of nicotine actions: studies with positron emission tomography.
    Volkow ND; Fowler JS; Ding YS; Wang GJ; Gatley SJ
    Nicotine Tob Res; 1999; 1 Suppl 2():S127-32; discussion S139-40. PubMed ID: 11768169
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased left posterior parietal-temporal cortex activation after D-fenfluramine in women with panic disorder.
    Meyer JH; Swinson R; Kennedy SH; Houle S; Brown GM
    Psychiatry Res; 2000 May; 98(3):133-43. PubMed ID: 10821996
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cholinergic enhancement improves performance on working memory by modulating the functional activity in distinct brain regions: a positron emission tomography regional cerebral blood flow study in healthy humans.
    Furey ML; Pietrini P; Alexander GE; Schapiro MB; Horwitz B
    Brain Res Bull; 2000 Feb; 51(3):213-8. PubMed ID: 10718513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers.
    Sofuoglu M; Mouratidis M; Yoo S; Culligan K; Kosten T
    Psychopharmacology (Berl); 2005 Sep; 181(3):504-10. PubMed ID: 15983800
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nicotine dependence in cigarette smoking: an empirically-based, multivariate model.
    Pomerleau OF; Fertig JB; Shanahan SO
    Pharmacol Biochem Behav; 1983 Aug; 19(2):291-9. PubMed ID: 6634878
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms.
    Hurt RD; Offord KP; Croghan IT; Croghan GA; Gomez-Dahl LC; Wolter TD; Dale LC; Moyer TP
    Psychopharmacology (Berl); 1998 Nov; 140(1):98-104. PubMed ID: 9862408
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proposal of blood volume-corrected model for quantification of regional cerebral blood flow with H2 15O-PET and its application to AVF.
    Seki C; Momose T; Kojima Y; Sasaki Y; Ohtomo K; Yokoyama I
    Radiat Med; 2006 May; 24(4):260-8. PubMed ID: 16958399
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Health Effects Accompanying the Transition from Cigarettes to Heat-not-burn Tobacco: Nicotine Dependence, Nicotine Withdrawal Symptoms, and Changes in Smoking Behaviors].
    Kawamura K; Yamada K; Morioka I
    Nihon Eiseigaku Zasshi; 2018; 73(3):379-387. PubMed ID: 30270306
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine.
    Gourlay SG; Benowitz NL
    Clin Pharmacol Ther; 1997 Oct; 62(4):453-63. PubMed ID: 9357397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypofrontality and negative symptoms in major depressive disorder.
    Galynker II; Cai J; Ongseng F; Finestone H; Dutta E; Serseni D
    J Nucl Med; 1998 Apr; 39(4):608-12. PubMed ID: 9544664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of antipsychotics on regional cerebral blood flow measured with positron emission tomography.
    Miller DD; Andreasen NC; O'Leary DS; Rezai K; Watkins GL; Ponto LL; Hichwa RD
    Neuropsychopharmacology; 1997 Oct; 17(4):230-40. PubMed ID: 9326747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.